[1]
Abrahao AC, Bonelli BV, Nunes FD, Dias EP, Cabral MG. Immunohistochemical expression of p.53, p.16 and hTERT in oral squamous cell carcinoma and potentially malignant disorders. Braz Oral Res. 2011; 25(1): 34-41.
DOI: 10.1590/s1806-83242011000100007
Google Scholar
[2]
Aman RA, Gondhowiharjo S, Rachman A, Suriadiredja ASD, dkk. Basic Science of Oncology-Ilmu Onkologi Dasar. Perhimpunan Onkologi Indonesia. Edisi ke-1. Jakarta: Badan Penerbit Fakultas Kedokteran UI; 2010. pp.11-53, 60-1, 176, 304-05.
Google Scholar
[3]
Artandi SE, DePinho RA. Telomeres and telomerase in cancer. Carcinogenesis. 2010;31(1): 9-18.
DOI: 10.1093/carcin/bgp268
Google Scholar
[4]
Barker G, Baughman RA, Burzynski N, Eversole LR, Flaitz K, Fu K, et al. Oral Cancer Background Papers. [download in 5 April 2013]. http://www.oralcancerfoundation.org.
Google Scholar
[5]
Blackburn EH, Seidel J. Telomere Extension by Telomerase. 2006 [download 1 April 2013]. www.gallus.reactome.org.
Google Scholar
[6]
Boslooper K, Yin Lam AK, Gao J, Weinstein S, Johnson N. The clinicopathological roles of alpha b-crystalin and p.53 expression in patients with head and neck squamous cell carcinoma. An Abstract of the paper was presented in the First World Congress of the International Academy of Oral Pathology, at Amsterdam. 2007. pp.1-11.
DOI: 10.1080/00313020802198010
Google Scholar
[7]
Cawson RA, Odell EW, Porter S. Cawson's Essentials of Oral Pathology and Oral Medicine. Edisi ke-7. London: Churchill Livingstone-Elsevier Science. 2002. pp.243-53.
Google Scholar
[8]
Cell cycle image. [download in 11 november 2013]. : www.gleesonbiology.pbworks.com.
Google Scholar
[9]
Chang LY, Lin SC, Chang CS, Wong YK, Hu YC, Chang KW. Telomerase activity and in situ telomerase RNA expression in oral carcinogenesis. J Oral Pathol Med. 1999;(28): 389-96.
DOI: 10.1111/j.1600-0714.1999.tb02109.x
Google Scholar
[10]
Choi S, Myers JN. Molecular pathogenesis of oral squamous cell carcinoma: implications for therapy. J Dent Res. 2008;87(1): 14-25.
DOI: 10.1177/154405910808700104
Google Scholar
[11]
Cong YS, Wright WE, Shay JW. Human telomerase and its regulation. Microbiol Molecular Biol Rev 2002;66(3):407-25.
DOI: 10.1128/mmbr.66.3.407-425.2002
Google Scholar
[12]
Cote R, Taylor CR. Immunohistochemistry and Related Marking Technique. Dalam: Ivan D and Linder J, editor. Anderson's Pathology. Edisi ke-10. St. Louis: CV Mosby Co; 1996. hlm.136.
Google Scholar
[13]
Curran AJ, Denis KS, Irish J, MD, Gullane PJ, Macmillan C, Reid SK, Telomerase activity in oral squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 1998;(124): 784-8.
DOI: 10.1001/archotol.124.7.784
Google Scholar
[14]
Deng Y, Chang S. Role of telomeres and telomerase in genomic instability, senescence and cancer. Laboratory Investigation. 2007;87:1071-6.
DOI: 10.1038/labinvest.3700673
Google Scholar
[15]
Epstein J, Waal van Der. Oral Cancer. Dalam: Greenberg MS, Glick M, Ship JA, editor. Burkets Oral Medicine. 11th ed. New York: BC Becker Inc; 2008. pp.153-71.
Google Scholar
[16]
Freier K, Pungs S, Flechtenmacher C, Bosch FX, Lichter P, Joos S, et al. Frequent high telomerase reverse transcriptase expression in primary oral squamous cell carcinoma. J Oral Pathol Med. 2007;36:267-72.
DOI: 10.1111/j.1600-0714.2007.00531.x
Google Scholar
[17]
Gede Sukardja ID. Onkologi Klinik. Edisi ke-2. Surabaya: Airlangga University Press; 2000. pp.13-83.
Google Scholar
[18]
Jain V, Maheshwari V, Mehdi G, Alam K, Sharma SC. Diagnostic and prognostic significance of p.53 protein expression in squamous cell lesions of the oral cavity. Internet J Otorhinolaryngol 2008;7(2):1-6.
Google Scholar
[19]
Jayade BV, Bhat K, Patil BR, Nayak R, Sant A. Histological significance of p.53 gene expression in squamous cell carcinoma of the buccal mucosa. J Maxillofac Oral Surg 2009;8(3):205-10.
DOI: 10.1007/s12663-009-0051-6
Google Scholar
[20]
Komite Nasional Etik Penelitian Kesehatan Departemen Kesehatan RI. Pedoman Nasional Etik Penelitian Kesehatan. Suplemen I Etik Pemanfaatan Bahan Biologik Tersimpan. Jakarta: Badan Penelitian dan Pengembangan Kesehatan Depkes RI. 2006. p.1,11-3.
DOI: 10.14203/press.298
Google Scholar
[21]
Kopnin BP. Targets of oncogenes and tumor suppressors: key for understanding basic mechanisms of carcinogenesis. Biochemistry Moscow. 2000;645(1):2-27.
Google Scholar
[22]
Kresno SB. Ilmu Dasar Onkologi. Jakarta: Fakultas Kedokteran Indonesia; 2002. pp.6-7.
Google Scholar
[23]
Kumar GL, Rudbeck L. Immunohistochemical Staining Methods Educational Guide. Edisi ke-5. California: DAKO Co Carpinteris; 2009. pp.1-60.
Google Scholar
[24]
Kumar SKS, Zain RB, Ismail sm, Abraham T, Cheong SC. hTERT Expression and Telomerase Activity in Oral Carcinogenesis. J Exp Clin Cancer Res 2005;24(4):639-46.
Google Scholar
[25]
Kumar V, Cotran RS, Robbins SL. Buku Ajar Patologi. Edisi ke-7. Jakarta: Penerbit Buku Kedokteran EGC; 2007. pp.31-2, 207-13.
Google Scholar
[26]
Kumar, Abbas, Fausto, Aster. Robbins and Cotran, Pathologic Basis of Disease. Edisi ke-8, Philadelphia: WB Saunders Co; 2010. p.259, 280,309-13, 739, 747.
Google Scholar
[27]
Madiyono B, Moeslichan Z, Sastroasmoro S, Budiman I, Purwanto SH. Perkiraan Besar Sampel. In: Sastroasmoro S, Ismael S, editor. Dasar-dasar Metodologi Penelitian Klinis. Edisi ke-4. Jakarta: CV. Sagung Seto; 2011. p.372.
Google Scholar
[28]
Maliya A. Perubahan Sel Menjadi Kanker Dari Sudut Pandang Biologi Molekuler. Infokes Maret–Sptember. 2004;8(1):1-7.
Google Scholar
[29]
Manullang K. Deteksi dini keganasan dalam rongga mulut. Majalah PABMI. Edisi Khusus April. 2001;69–81.
Google Scholar
[30]
Manyaha TB. Panduan kanker solid PERABOI. Jakarta: Sagung Seto; 2010. p.102.
Google Scholar
[31]
Mao L, Hong WK, Papadimitrakopoulou VA. Focus on head and neck cancer. Cancer Cell. 2004;5:311-6.
DOI: 10.1016/s1535-6108(04)00090-x
Google Scholar
[32]
Mehrotra R, Yadav S. Oral squamous cell carcinoma: Etiology, pathogenesis and prognostic value of genomic alterations. Indian J Cancer. 2006;43(2):60-6.
DOI: 10.4103/0019-509x.25886
Google Scholar
[33]
Michael M, Ghali GE, Peter EL, Peter DW. Peterson's Principles of Oral and Maxillofacial Surgery. Hamilton London: BC Decker Inc; 2004. pp.569-72, 617-23.
Google Scholar
[34]
Mitchell RD, Kumar V, Abbas AK, Fausto N, Robbins & Cotran buku saku dasar patologis penyakit. Edisi ke-7. Jakarta: EGC; 2006. pp.26-27, 190.
Google Scholar
[35]
Mitchell RD, Kumar V, Abbas AK, Fausto N. Robbins & Cotran Buku Saku Dasar Patologis Penyakit. Edisi ke-7. Jakarta: Penerbit Buku Kedokteran EGC; 2006. pp.172-73, 204.
Google Scholar
[36]
Nevile BW, Damm DD, Allen CM. Bouquot J.E. Oral and Maxillofacial Pathology. Edisi ke-2. Philadelphia: WB Saunders Co.; 2002. pp.356-67.
Google Scholar
[37]
Palani J, Lakshminarayanan V, Kannan R. Immunohistochemical detection of human telomerase reverse transcriptase in oral cancer and pre-cancer. Indian J Dent Res 2011;22(2): 362-63.
DOI: 10.4103/0970-9290.84281
Google Scholar
[38]
Rahman R, Latonen L, Wiman KG. hTERT antagonizes p.53-induced apoptosis independently of telomerase activity. Oncogene - Nature Publishing Group. 2005;(24):1320-7.
DOI: 10.1038/sj.onc.1208232
Google Scholar
[39]
Ratnawati H. Enzim telomerase dan karsinogenesis. J Kedokteran Maranatha. 2002; 2(1):39-50.
Google Scholar
[40]
Regezi JA, Sciuba JJ, Jordan RCK. Oral Pathology Correlations. Edisi ke-4. St. Louis Missouri: WB Saunders Co; 2003. pp.77-138.
Google Scholar
[41]
Rosai J. Rosai and Ackerman's Surgical Pathology. 10th ed. New York: Mosby Elsevier Inc; 2011. pp.247-57.
Google Scholar
[42]
Sapp JP, Eversole LR, Wysocki GP. Contemporary oral and Maxillofacial Pathology. 2rd ed. St. Louis: Mosby Inc; 2004. pp.134-43, 184-96.
DOI: 10.1016/b978-0-323-01723-7.50010-0
Google Scholar
[43]
Sharma S. Tumor markers in clinical practice: General principles and guidelines. Indian J Med Paediatr Oncol. 2009;30(1):1–8.
DOI: 10.4103/0971-5851.56328
Google Scholar
[44]
Shay JW, Wright WE. Senescence and immortalization: role of telomeres and telomerase. Carcinogenesis. 2005;26(5): 867-74.
DOI: 10.1093/carcin/bgh296
Google Scholar
[45]
Siegel S. Koefisien Korelasi Parsial Kendall: T.y.z Koefisien Konkordansi Kendall: W. In: Siegel S. Statistik Nonparametrik Untuk Ilmu -ilmu Sosial. Jakarta: PT. Gramedia Pustaka Utama; 1997. pp.283-296.
Google Scholar
[46]
Slootweg PJ, Everson JW. Tumours of the oral cavity and oropharynx. Dalam: Barnes I, Everson JW, Reichart P, Sidransky, editor. Pathology and Genetics of Head and Neck Tumours. World Health Organization Classificaion of Tumours. Lyon: IARC Press; 2005. pp.166-75.
Google Scholar
[47]
Sugiyono. Statistika Untuk Penelitian. Bandung: Penerbit Alfabeta; 2013. pp.244-253.
Google Scholar
[48]
Xu D, Wang Q, Gruber A, Bjorkholm M, Chen Z, Zaid A, et al. Downregulation of telomerase reverse transcriptase mRNA expression by wild type p.53 in human tumor cells. Oncogene-Nature Publishing Group. 2000;(19): 5123-133.
DOI: 10.1038/sj.onc.1203890
Google Scholar
[49]
Zhang XH, Mei KY, Chen GS. Expressions of human telomerase reverse transcriptase, p.53 and MIB-1 proteins in oral squamous cell carcinoma and their clinical significance. Chinese Journal of Biomedical Engineering [abstract]. 2012 [download in 12 April 2013]; 18(2). Wanfang Med Online. http://eng.med.wanfangdata.com.cn.
Google Scholar